SCHEMBL1377889

SCHEMBL1377889

Nc1cccc(CC(c2cccnc2)(c2cccc(N)n2)c2cccc(N)n2)n1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
MEN1 O00255 1/20 0.33
PSIP1 O75475 1/20 0.33
AXL P30530 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
BACE1 P56817 2/20 0.33
CYP19A1 P11511 3/20 0.33
TSHR P16473 1/20 0.33
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380210 0.93 KCNA5 (0.40) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3819751 0.93 CYP1A2 (0.35) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1382631 0.87 CYP1A2 (0.37) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1380492 0.86 KIF11 (0.35) CYP3A4BACE1CYP19A1
SCHEMBL3814663 0.85 BACE1 (0.33) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1377502 0.83 KCNH3 (0.39) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1381592 0.79 CYP19A1 (0.41) CYP3A4CYP19A1
SCHEMBL3813876 0.75 CYP1A2 (0.35) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1378654 0.74 CYP3A4 (0.39) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1375862 0.73 L3MBTL1 (0.34) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719744-B2 2011-07-06 JP claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP claimed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP claimed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed